Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks
Hereditary angioedema (HAE) is characterized by unpredictable, recurring and painful swelling episodes that can be disabling or even life-threatening. Awareness of HAE has progressively grown worldwide, and options for treatment of acute attacks and prevention of future attacks continue to expand; h...
Main Authors: | Michihiro Hide, Takahiko Horiuchi, Isao Ohsawa, Irmgard Andresen, Atsushi Fukunaga |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893020301027 |
Similar Items
-
Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
by: Werner Aberer, et al.
Published: (2017-07-01) -
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study
by: Teresa Caballero, et al.
Published: (2018-03-01) -
Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom
by: Hilary J. Longhurst, et al.
Published: (2018-08-01) -
Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedema
by: Isao Ohsawa, et al.
Published: (2021-02-01) -
Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey
by: Anette Bygum, et al.
Published: (2019-07-01)